Heart check for delgocitinib: no cure, just safety data
NCT ID NCT05050279
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether the drug delgocitinib changes heart rhythms in 40 healthy adults. Participants took the drug or a placebo, and their heart activity was measured with ECGs. The goal was to check for possible heart risks, not to treat any disease. Since it involved healthy people and only measured safety, there was no direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Labcorp Clinical Research Unit (CRU) Ltd, Springfield House, Hyde Street,
Leeds, LS2 9LH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test